Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
George Yancopoulos
Pharma
Without equity awards, Regeneron's Schleifer made $7M in 2022
Regeneron CEO Len Schleifer collected $7M in 2022, while chief scientific officer George Yancopoulos pulled down $6.6M, according to an SEC filing.
Kevin Dunleavy
Apr 24, 2023 10:32am
Legendary Regeneron chairman Roy Vagelos to retire at age 93
Apr 17, 2023 10:34am
Regeneron buys rights to Libtayo from Sanofi for $900M
Jun 2, 2022 10:14am
In swan song, Regeneron's antibodies sold $2.3B in 4th quarter
Feb 4, 2022 10:45am
REGEN-COV provides 81.6% efficacy over 8 months as a prophylaxis
Nov 8, 2021 9:17am
Antibody sales propel Regeneron to 163% increase in revenue
Aug 5, 2021 11:09am
